Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation Cell Therapy 2014

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Presenter: Birgit Assmus

January 22, 2014

Presentation Cell Therapy 2013

Pivotal Study Design and Logistics: The BAMI Study

Presenter: Andreas M. Zeiher

January 24, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation Cell Therapy 2013

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Presenter: Jonathan Sackner-Bernstein

January 22, 2013

Presentation Cell Therapy 2012

Design and Rationale for the RENEW Study

Presenter: Thomas J. Povsic

January 26, 2012

Presentation Cell Therapy 2012

ACT 34 CMI Update and Phase 3 Study Design

Presenter: Timothy Henry

January 25, 2012

Advertisement

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Pivotal Study Design and Logistics: The BAMI Study

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

EXCELLENT Trial Design

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Design and Rationale for the RENEW Study

ACT 34 CMI Update and Phase 3 Study Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content